博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300318 博晖创新

已收盘 07-30 15:00:00

{"stockData":{"symbol":"300318","market":"SZ","secType":"STK","nameCN":"博晖创新","latestPrice":4.66,"timestamp":1722322983000,"preClose":4.6,"halted":0,"volume":3842000,"delay":0,"floatShares":799000000,"shares":817000000,"eps":-0.0126,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"07-30 15:00:00","open":4.65,"high":4.69,"low":4.59,"amount":17870500,"amplitude":0.0217,"askPrice":4.67,"askSize":880,"bidPrice":4.66,"bidSize":361,"shortable":0,"etf":0,"ttmEps":-0.0126,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722389400000},"adr":0,"adjPreClose":4.6,"symbolType":"stock","openAndCloseTimeList":[[1722303000000,1722310200000],[1722315600000,1722322800000]],"highLimit":5.06,"lowLimit":4.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":816900495,"pbRate":2.7,"roa":"--","roe":"1.44%","epsLYR":-0.0305,"committee":-0.200702,"marketValue":3807000000,"floatMarketCap":3721000000,"peRate":-369.841269,"changeRate":0.013,"turnoverRate":0.0048,"status":0},"requestUrl":"/m/hq/s/300318/wiki","defaultTab":"wiki","newsList":[{"id":"2454528260","title":"博晖创新：公司2024年上半年采浆量请关注公司将于2024年8月30日披露的《2024年半年度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2454528260","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454528260?lang=zh_cn&edition=full","pubTime":"2024-07-28 21:00","pubTimestamp":1722171629,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新07月28日在投资者关系平台上答复投资者关心的问题。公司2024年上半年采浆量请关注公司将于2024年8月30日披露的《2024年半年度报告》。随着公司采浆规模的逐步扩大，产品文号的不断丰富，公司血液制品业务毛利率将不断缩短与行业领先企业的差距。公司人凝血因子VIII目前处于上市许可注册申报阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072800001893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","300318","BK0251","BK0028"],"gpt_icon":0},{"id":"2454547205","title":"博晖创新:人凝血因子VIII上市许可注册申报阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2454547205","media":"问董秘","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454547205?lang=zh_cn&edition=full","pubTime":"2024-07-28 19:55","pubTimestamp":1722167700,"startTime":"0","endTime":"0","summary":"投资者提问：请问公司八因子上市申请是否已获受理？董秘回答(博晖创新SZ300318)：尊敬的投资者，您好！公司人凝血因子VIII目前处于上市许可注册申报阶段。感谢您的关注！查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-07-28/doc-incfswvy9950359.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-07-28/doc-incfswvy9950359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0048","BK0251","BK0028","300318"],"gpt_icon":0},{"id":"2449500753","title":"博晖创新：公司如有分红计划将严格履行相关的流程并进行披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2449500753","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449500753?lang=zh_cn&edition=full","pubTime":"2024-07-07 16:00","pubTimestamp":1720339240,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新07月07日在投资者关系平台上答复投资者关心的问题。公司如有分红计划将严格履行相关的流程并进行披露。相关财务数据，请持续关注公司定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070700001603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0048","300318","BK0251"],"gpt_icon":0},{"id":"2444845169","title":"博晖创新获得发明专利授权：“氢化反应一体装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2444845169","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444845169?lang=zh_cn&edition=full","pubTime":"2024-06-19 02:17","pubTimestamp":1718734663,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示博晖创新新获得一项发明专利授权，专利名为“氢化反应一体装置”，专利申请号为CN201811312396.8，授权日为2024年6月18日。今年以来博晖创新新获得专利授权4个。结合公司2023年年报财务数据，2023年公司在研发方面投入了6920.28万元，同比增6.83%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900002178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318","BK0028","BK0251","BK0048"],"gpt_icon":0},{"id":"2440166691","title":"博晖创新：截止目前，公司尚没有制定相关计划，相关事项如有动向将严格履行相关的流程并进行披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2440166691","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440166691?lang=zh_cn&edition=full","pubTime":"2024-06-02 13:00","pubTimestamp":1717304430,"startTime":"0","endTime":"0","summary":"目前，云南大关、云南永善、云南彝良浆站已验收完毕，等待获批执业许可；内蒙古和林格尔浆站、内蒙古土默特左旗浆站、云南姚安浆站、云南禄劝浆站处于验收前准备阶段。截止目前，公司尚没有制定相关计划，相关事项如有动向将严格履行相关的流程并进行披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060200000976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318","BK0028","BK0048","BK0251"],"gpt_icon":0},{"id":"2436114885","title":"血液制品概念盘中拉升，博晖创新涨4.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436114885","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436114885?lang=zh_cn&edition=full","pubTime":"2024-05-20 09:38","pubTimestamp":1716169121,"startTime":"0","endTime":"0","summary":"05月20日，血液制品概念盘中拉升，截至09点38分，血液制品概念整体指数上涨0.54%，报799.080点。从个股上来看，该概念的成分股中，博晖创新涨4.65%，君正集团、健帆生物、天坛生物涨幅居前。从资金上来看，截止发稿，血液制品概念概念主力净流入为357.46万，其中天坛生物受到资金热捧，主力净流入464.03万；拉长时间线来看，该板块近20日主力资金净流入-7.53亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520093841861eddc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520093841861eddc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0185","BK0188","600161","BK0082","BK0239","BK0168","BK0251","BK0048","BK0046","300318","BK0010"],"gpt_icon":0},{"id":"2435578926","title":"【机构调研记录】天弘基金调研海尔生物、博晖创新等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2435578926","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435578926?lang=zh_cn&edition=full","pubTime":"2024-05-15 08:01","pubTimestamp":1715731307,"startTime":"0","endTime":"0","summary":"3）中通客车 个股亮点：公司产品包括氢燃料电池客车，且车型谱涵盖8米-12米的公交车及旅团车；公司智能驾驶客车已实现开放道路场景跑车测试，并达到智能驾驶L4级水平。天弘基金成立于2004年，截至目前，资产管理规模11380.86亿元，排名5/203；资产管理规模3481.27亿元，排名14/203；管理公募基金数358只，排名16/203；旗下公募基金经理49人，排名18/203。旗下最近一年表现最佳的公募基金产品为天弘中证中美互联网A，最新单位净值为1.18，近一年增长39.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500011082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0251","300318","688139","BK0028"],"gpt_icon":0},{"id":"2433713689","title":"博晖创新（300318）5月8日主力资金净买入1337.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433713689","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433713689?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:19","pubTimestamp":1715152772,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月8日收盘，博晖创新报收于5.67元，上涨5.98%，换手率3.3%，成交量26.32万手，成交额1.47亿元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：博晖创新2024年一季报显示，公司主营收入2.62亿元，同比上升3.6%；归母净利润1986.36万元，同比上升283.9%；扣非净利润1836.63万元，同比上升330.1%；负债率40.21%，财务费用626.94万元，毛利率49.55%。博晖创新主营业务：检验检测及生物制品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800021184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0048","300318","BK0251"],"gpt_icon":0},{"id":"2430870250","title":"博晖创新：公司将继续聚焦主业，落实既定战略，狠抓科学管理，不断提高盈利水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2430870250","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430870250?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:00","pubTimestamp":1714291259,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新(300318)04月28日在投资者关系平台上答复投资者关心的问题。投资者：其它血制品企业净利润为30%左右，公司是不是故意隐藏利润，请问目的是什么？博晖创新董秘：尊敬的投资者，您好！公司将继续聚焦主业，落实既定战略，狠抓科学管理，不断提高盈利水平。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800003384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300318","BK0028","BK0048"],"gpt_icon":0},{"id":"2430273753","title":"博晖创新最新公告：一季度净利润1986.36万元 同比增长283.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430273753","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430273753?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:50","pubTimestamp":1714132207,"startTime":"0","endTime":"0","summary":"博晖创新公布2024年第一季度报告，报告期营业收入2.62亿元，同比增长3.60%；归属于上市公司股东的净利润1986.36万元，同比增长283.90%；归属于上市公司股东的扣除非经常性损益的净利润1836.63万元，同比增长330.10%；基本每股收益0.0243元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600049656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318"],"gpt_icon":0},{"id":"2430822859","title":"博晖创新(300318.SZ)发布一季度业绩，净利润1986万元，同比增长283.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430822859","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430822859?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:20","pubTimestamp":1714123215,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博晖创新(300318.SZ)发布2024年第一季度报告，报告期内实现营业收入2.62亿元，同比增长3.60%，实现归属于上市公司股东的净利润1986万元，同比增长283.90%，实现归属于上市公司股东的扣除非经常性损益的净利润1837万元，同比增长330.10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300318"],"gpt_icon":0},{"id":"2430341492","title":"图解博晖创新年报：第四季度单季净利润同比增0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430341492","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430341492?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:03","pubTimestamp":1714064598,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新2023年年报显示，公司主营收入10.45亿元，同比上升31.35%；归母净利润-2492.94万元，同比上升68.22%；扣非净利润-2765.77万元，同比上升71.1%；其中2023年第四季度，公司单季度主营收入2.39亿元，同比上升20.55%；单季度归母净利润-3906.66万元，同比上升0.14%；单季度扣非净利润-3977.2万元，同比上升28.03%；负债率40.38%，投资收益149.73万元，财务费用2584.31万元，毛利率43.51%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600000961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-05-23","address":"北京市昌平区生命园路9号","stockEarnings":[{"period":"1week","weight":-0.0612},{"period":"1month","weight":-0.0574},{"period":"3month","weight":-0.1171},{"period":"6month","weight":-0.0456},{"period":"1year","weight":-0.1712},{"period":"ytd","weight":-0.2628}],"companyName":"北京博晖创新生物技术集团股份有限公司","boardCode":"AI0035","perCapita":"21120股","boardName":"专用设备制造业","registeredCapital":"81690万元","compareEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":-0.0255},{"period":"3month","weight":-0.0686},{"period":"6month","weight":0.037},{"period":"1year","weight":-0.1172},{"period":"ytd","weight":-0.0279}],"survey":"　　北京博晖创新生物技术集团股份有限公司的主营业务为检验检测业务及生物制品业务。公司主要产品有HPV检测产品、微量元素检测产品、质谱相关检测产品、其他耗材及服务、人血白蛋白、静注人免疫球蛋白、其他血液制品。","serverTime":1722325598872,"listedPrice":15,"stockholders":"37809人(较上一季度增加7.68%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博晖创新,300318,博晖创新股票,博晖创新股票老虎,博晖创新股票老虎国际,博晖创新行情,博晖创新股票行情,博晖创新股价,博晖创新股市,博晖创新股票价格,博晖创新股票交易,博晖创新股票购买,博晖创新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}